APOE‐ε4 carriers have superior recall on the ‘What was where?’ visual short‐term memory binding test at age 70, despite a detrimental effect of β‐amyloid

Kirsty Lu; Jennifer M. Nicholas; Yoni Pertzov; John Grogan; Masud Husain; Ivanna M. Pavisic; Sarah‐Naomi James; Thomas D. Parker; Christopher A Lane; Ashvini Keshavan; Sarah E. Keuss; Sarah M. Buchanan; Heidi Murray‐Smith; David M. Cash; Ian B. Malone; William Coath; Andrew Wong; Susie M.D. Henley; Sebastian J. Crutch; Nick C. Fox; Marcus Richards; Jonathan M. Schott

Journal ArticleOPEN ACCESS

APOE‐ε4 carriers have superior recall on the ‘What was where?’ visual short‐term memory binding test at age 70, despite a detrimental effect of β‐amyloid

Lu K
Nicholas J
Pertzov Y
et al.

Alzheimer's & Dementia (2020) 16(S6)

DOI: 10.1002/alz.041090

N/ACitations

8Readers

Abstract

Background: While APOE-ε4 carriers are at higher risk of Alzheimer's disease (AD),

Cite

CITATION STYLE

APA

Lu, K., Nicholas, J. M., Pertzov, Y., Grogan, J., Husain, M., Pavisic, I. M., … Schott, J. M. (2020). APOE‐ε4 carriers have superior recall on the ‘What was where?’ visual short‐term memory binding test at age 70, despite a detrimental effect of β‐amyloid. Alzheimer’s & Dementia, 16(S6). https://doi.org/10.1002/alz.041090

APOE‐ε4 carriers have superior recall on the ‘What was where?’ visual short‐term memory binding test at age 70, despite a detrimental effect of β‐amyloid

Abstract

Cite

Register to see more suggestions